Pentech Pharmaceuticals is Drug Discovery in United States that focus on system conditions business. Founded in 1993. They cover business area such as developer, novel drug therapy, management, adolescent lifestyle condition, commercialization, prescription drug therapy, delivery system, application, disease, sexual dysfunction, Parkinson, depression, nervous system condition, patient.
1993
( 33 years old in 2026 )
System Conditions
-
3315 West Algonquin Road
Suite 310
Rolling Meadows, IL 60008
United States
Private
developernovel drug therapymanagementadolescent lifestyle conditioncommercializationprescription drug therapydelivery systemapplicationdiseasesexual dysfunctionParkinsondepressionnervous system conditionpatient
* We use standard office opening hours in near Pentech Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pentech Pharmaceuticals is Drug Discovery business from United States that founded in 1993 (33 years old in 2026), Pentech Pharmaceuticals business is focusing on System Conditions.
Pentech Pharmaceuticals headquarter office and corporate office address is located in 3315 West Algonquin Road Suite 310 Rolling Meadows, IL 60008 United States.
Pentech Pharmaceuticals was founded in United States.
In 2026, Pentech Pharmaceuticals is currently focus on system conditions sector.
Above is snippet of Google Trends for "system conditions" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pentech Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
